Company news
Champions Oncology, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
December 12, 2022
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022
December 8, 2022
Submission of Matters to a Vote of Security Holders - Form 8-K
October 20, 2022
Submission of Matters to a Vote of Security Holders (form 8-K)
October 20, 2022
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
September 9, 2022
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
September 7, 2022
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022
September 5, 2022
Champions Oncology Reports Quarterly Revenue of $12.9 Million
July 20, 2022
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022
July 13, 2022
Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics
May 30, 2022
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
May 2, 2022
Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million
March 14, 2022
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022
March 10, 2022
Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors
February 14, 2022
Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates
January 19, 2022
Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs
January 3, 2022
Champions Oncology Reports Record Quarterly Revenue of $11.8 Million
December 12, 2021
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021
December 5, 2021
Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus
October 19, 2021
Champions Oncology Reports Record Quarterly Revenue of $11.3 Million
September 12, 2021
Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021
September 1, 2021
Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development
July 25, 2021
Champions Oncology Reports Quarterly Revenue of $10.6 Million
July 21, 2021
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021
July 13, 2021
Champions Oncology and BGI Americas Announce a Strategic Partnership to Provide Mass Spectrometry Proteomics, Metabolomics, and Multi-Omic Data Analysis Solutions
June 14, 2021
Champions Oncology Reports Record Quarterly Revenue of $10.8 Million
March 10, 2021
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 11, 2021
March 4, 2021
Champions Oncology Announces Addition to Board of Directors
February 21, 2021
Champions Oncology Announces Partnership with Code Ocean to Expand the Functionality of Lumin Bioinformatics
January 18, 2021
Champions Oncology Announces the Expansion of Lumin Bioinformatics: Now Featuring a Highly Valuable Set of Proteomic Data and Analytics
January 4, 2021
Champions Oncology Reports Record Quarterly Revenue of $10.1 Million
December 13, 2020
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 14, 2020
December 6, 2020
Champions Oncology Announces the Launch of Lumin Bioinformatics, Its New Oncology Data-Driven SaaS Program
November 15, 2020
Champions Oncology Expands Its Immuno-Oncology Research Offering by Launching a Unique Autologous Tumor Infiltrating Lymphocyte Ex Vivo Platform
November 10, 2020
Champions Oncology Reports Record Quarterly Revenue of $9.5 Million
September 13, 2020
Champions Oncology to Announce First Quarter Financial Results on Monday, September 14, 2020
September 7, 2020
Champions Oncology Reports Quarterly Revenue of $8.8 Million
July 26, 2020
Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 27, 2020
July 21, 2020
Champions Oncology Reports Record Quarterly Revenue of $9.0 Million
March 11, 2020
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2020
March 9, 2020
Champions Oncology Reports Quarterly Revenue of $7.6 Million
December 15, 2019
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 16, 2019
December 8, 2019
Champions Oncology and PhenoVista Biosciences Announce a Strategic Partnership to provide Oncology Imaging-based Phenotypic Assays for Preclinical Drug Development
November 12, 2019
Champions Oncology Reports Quarterly Revenue of $6.7 Million
September 15, 2019
Champions Oncology to Announce First Quarter Financial Results on Monday, September 16, 2019
September 8, 2019
Calls
The 5 newest of 23 calls. Every call is listed under its year.
- Champions Oncology (NASDAQ:CSBR) Q1 2027 Earnings Call
Sep 10, 2026
Transcript - Champions Oncology (NASDAQ:CSBR) Q4 2026 Earnings Call
Jul 27, 2026
Transcript - Champions Oncology (NASDAQ:CSBR) Q3 2026 Earnings Call
Mar 12, 2026
Transcript - Champions Oncology (NASDAQ:CSBR) Q2 2026 Earnings Call
Dec 15, 2025
Transcript - Champions Oncology (NASDAQ:CSBR) Q1 2026 Earnings Call
Sep 15, 2025
Transcript
Decks
The 5 newest of 10 decks. Every deck is listed under its year.
- Investor Presentation (March 2021)
Investor deck · 23 slides · March 2021
- Investor Presentation (October 2020)
Investor deck · 22 slides · Oct 15, 2020
- Investor Presentation (January 2020)
Investor deck · 26 slides · Jan 3, 2020
- Investor Presentation (September 2019)
Investor deck · 22 slides · Sep 5, 2019
- Investor Presentation (January 2019)
Investor deck · 20 slides · Jan 7, 2019